News

Law

Asset Management

Investment Banking

Wealth

Hedge Funds

People

Newsletters

Events

Lists

News

Oxford-AstraZeneca vaccine gets UK approval for immediate rollout as new variant takes hold

Individuals that are vaccinated will receive their second dose within 12 weeks of the first

Oxford-AstraZeneca's vaccine has been approved for use in the UK, with the first doses rolled out today, the UK government said in a joint statement with the firm. The announcement comes as Covid-19 cases surge past the first peak of infections seen during the first wave of the pandemic in April.
Oxford-AstraZeneca's vaccine has been approved for use in the UK, with the first doses rolled out today, the UK government said in a joint statement with the firm. The announcement comes as Covid-19 cases surge past the first peak of infections seen during the first wave of the pandemic in April. Photo: Getty Images

The government has approved the Oxford University-AstraZeneca’s Covid-19 vaccine for use upon the recommendation of the UK's regulator, the Medicines and Healthcare products Regulatory Agency.

The first doses will be released on 4 January to the most high-risk groups, the government said. Individuals that are vaccinated will receive their second dose within 12 weeks of the first, which will complete the dosage, which "is important for longer-term protection" according to the government.

WSJ Logo